Citations 2
Evaluation of Quality of Life and Disability in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Polyneuropathy Following Treatment with Patisiran, An Investigational RNAi Therapeutic: Results from the Phase 3 APOLLO Study (S31.003)
O’Riordan, William, Yamashita, Taro , Kristen, Arnt V. , Tournev, Ivaylo, Coelho, Teresa , Lin, Kong-Ping, Dyck, P. James B. , Gandhi, Pritesh J., Sweetser, Marianne T., Goyal, Sunita , Gollob, Jared , Adams, David , González-Duarte, Alejandra , Yang, Chih‐Chao , Schmidt, Hartmut , Berk, John L. , Chen, Jihong , Goyal, Sunita, Suhr, Ole B.
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available
Patisiran, an Investigational RNAi Therapeutic for Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Polyneuropathy: Results from the Phase 3 APOLLO study (CT.001)
O’Riordan, William, Yamashita, Taro , Kristen, Arnt V. , Tournev, Ivaylo, Coelho, Teresa , Lin, Kon‐Ping, Dyck, P. James B. , Gandhi, Pritesh J., Sweetser, Marianne T., Goyal, Sunita , Gollob, Jared , Adams, David , González-Duarte, Alejandra , Yang, Chih‐Chao , Schmidt, Hartmut , Berk, John L. , Lin, Kon‐Ping, Chen, Jihong , Goyal, Sunita, Suhr, Ole B.
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available